Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Spohn

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Medical Physics|February 26, 2026
A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapyDejan Kuhn, Simon K B Spohn, Constantinos Zamboglou, et al.
Nature Cell Biology|March 7, 2001
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cellsB P Zhou, Y Liao, W Xia, et al.
Oncogene|February 16, 1999
Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202D H Yan, Y Wen, B Spohn, et al.
Cancer Research|January 26, 2000
Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cellsY Wen, D H Yan, B Spohn, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 1, 1985
[Ultrasonically targetted fine-needle aspiration cytology in the immediate postoperative follow-up of transplanted kidneys]W Swobodnik, B Spohn, V Schusdziarra, et al.
Bio Systems|January 1, 1996
Evolving cooperation: the role of individual recognitionP H Crowley, L Provencher, S Sloane, et al.
Cancer Research|January 13, 2001
HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathwayY Wen, M C Hu, K Makino, et al.
Frontiers in Oncology|May 13, 2024
Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysisSimon K B Spohn, Gianluca Radicioni, Marcio Eisfelder, et al.
Cancer Research|October 5, 2001
p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft modelsY Wen, D H Yan, B Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progressionS Y Lin, W Xia, J C Wang, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Medical Physics|February 26, 2026
A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapyDejan Kuhn, Simon K B Spohn, Constantinos Zamboglou, et al.
Nature Cell Biology|March 7, 2001
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cellsB P Zhou, Y Liao, W Xia, et al.
Oncogene|February 16, 1999
Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202D H Yan, Y Wen, B Spohn, et al.
Cancer Research|January 26, 2000
Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cellsY Wen, D H Yan, B Spohn, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 1, 1985
[Ultrasonically targetted fine-needle aspiration cytology in the immediate postoperative follow-up of transplanted kidneys]W Swobodnik, B Spohn, V Schusdziarra, et al.
Bio Systems|January 1, 1996
Evolving cooperation: the role of individual recognitionP H Crowley, L Provencher, S Sloane, et al.
Cancer Research|January 13, 2001
HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathwayY Wen, M C Hu, K Makino, et al.
Frontiers in Oncology|May 13, 2024
Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysisSimon K B Spohn, Gianluca Radicioni, Marcio Eisfelder, et al.
Cancer Research|October 5, 2001
p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft modelsY Wen, D H Yan, B Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progressionS Y Lin, W Xia, J C Wang, et al.
Pageof 8